Problem

OUR PRODUCTS ADDRESS THE UNMET MEDICAL NEEDS IN THE AREAS OF ORTHOPEDICS, URO - GYNECOLOGY & ONCOLOGY. INDICATIONS: 1. AVASCULAR NECROSIS OF HIP JOINT FOR YOUNG PATIENTS (AGE 18 - 55 YEARS) Till date no standard of care available for AVN globally. 2. CARTILAGE DEFECTS OF KNEE, SPORTS INJURIES 3. TREATMENT FOR URETHRAL STRICTURES

Solutions

BIOLOGICAL REGENERATION OF TISSUE TARGETED CELLS, THAT STOPS DISEASE PROGRESSION & PROVIDES COMPLETE CURE. PRODUCTS ARE MEANT FOR CURE vs MANAGEMENT OF DISEASE. PATIENT CAN GET BACK TO NORMAL ACTIVITIES INCLUDING SPORTS AND NO REVISION SURGERY REQUIRED. • PATIENT ACTIVITY LEVELS ARE RESTORED, INCLUDING GETTING BACK TO PROFESSIONAL LEVEL SPORTS.

Brief description

Regrow has developed a proprietary & patented cell therapy platform to develop products for unmet clinical needs in the therapeutic areas including Orthopedics & Urogynecology. The procedure is minimally invasive where Autologous Cells are implanted back to patient body for regeneration of damaged tissues. This technology aims to provide biological and curative clinical benefits to patients with disability and life-threatening medical conditions. Advantage: • Curative VS Managing disease • Regrow single platform technology can be used for the development of therapies for multiple disease areas and indications. Product OSSGROW® can also be applied for Avascular Necrosis, Non Union Fractures, Bone Dysplasia, Spine & Maxillofacial Applications. Product UREGROW® can be applied for Urethral strictures, Hypospadias. • Uses patient’s own cells thus rendering complete safety.